A glucocorticoid dependent enhancer within the long terminal repeat (LTR) of Moloney murine sarcoma virus (MoMSV) has been identified that coresides with a hormone independent enhancer. The long term goal of this project is to examine within MoMSV and related C-type retroviruses, the relationship between distinct transcriptional regulatory elements, and uncover genetic strategies by which multiple regulatory properties are superimposed. Transient transfections will be performed into different cell types with in vitro generated MoMSV mutants to identify specific sequences that are necessary for hormone dependent and independent enhancers and reveal any cell type specificity of enhancer activity. We will also analyze glucocorticoid effects on the expression of endogenous C-type proviruses. Intact and hybrid MoMSV proviruses will be generated in various cell types by stable transfections, in order to test the effect of proviral context and examine the kinetics, cell type specificity and cellular heterogeneity of the glucocorticoid response of C-type retroviruses. In addition, the transcriptional effects of glucocorticoids on endogenous xenotropic proviruses will be studied and viral sequences reponsible for the hormone response identified by cDNA cloning. Finally, we will analyze the molecular basis for the differential activity of distinct MoMSV enhancers in undifferentiated embryonal carcinoma cells. Both transient and stable transfections will be performed with MoMSV DNA to examine both cis- and trans-acting mechanisms that influence glucocorticoid regulated expression.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA043037-01
Application #
3184883
Study Section
Virology Study Section (VR)
Project Start
1986-07-01
Project End
1989-06-30
Budget Start
1986-07-01
Budget End
1987-06-30
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
Schools of Arts and Sciences
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Dekelbab, Bassem H; Witchel, Selma F; DeFranco, Donald B (2007) TNF-alpha and glucocorticoid receptor interaction in L6 muscle cells: a cooperative downregulation of myosin heavy chain. Steroids 72:705-12
Rasar, Melissa; DeFranco, Donald B; Hammes, Stephen R (2006) Paxillin regulates steroid-triggered meiotic resumption in oocytes by enhancing an all-or-none positive feedback kinase loop. J Biol Chem 281:39455-64
Heitzer, M D; DeFranco, D B (2006) Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator. Mol Endocrinol 20:56-64
Heitzer, Marjet D; DeFranco, Donald B (2006) Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells. Cancer Res 66:7326-33
Wang, Xinjia; DeFranco, Donald B (2005) Alternative effects of the ubiquitin-proteasome pathway on glucocorticoid receptor down-regulation and transactivation are mediated by CHIP, an E3 ligase. Mol Endocrinol 19:1474-82
Guerrero-Santoro, Jennifer; Yang, Lan; Stallcup, Michael R et al. (2004) Distinct LIM domains of Hic-5/ARA55 are required for nuclear matrix targeting and glucocorticoid receptor binding and coactivation. J Cell Biochem 92:810-9
Pratt, William B; Galigniana, Mario D; Harrell, Jennifer M et al. (2004) Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement. Cell Signal 16:857-72
Wang, Xinjia; Pongrac, Julie L; DeFranco, Donald B (2002) Glucocorticoid receptors in hippocampal neurons that do not engage proteasomes escape from hormone-dependent down-regulation but maintain transactivation activity. Mol Endocrinol 16:1987-98
Yang, L; Guerrero, J; Hong, H et al. (2000) Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol Biol Cell 11:2007-18
Liu, J; DeFranco, D B (2000) Protracted nuclear export of glucocorticoid receptor limits its turnover and does not require the exportin 1/CRM1-directed nuclear export pathway. Mol Endocrinol 14:40-51

Showing the most recent 10 out of 34 publications